Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Cardiovascular diseases (CVDs) are a major burden on the healthcare system: indeed, over two million new cases are diagnosed every year worldwide. Unfortunately, important drawbacks for the treatment of these patients derive from our current inability to stop the structural alterations that lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Milan, Marika, Pace, Valentina, Maiullari, Fabio, Chirivì, Maila, Baci, Denisa, Maiullari, Silvia, Madaro, Luca, Maccari, Sonia, Stati, Tonino, Marano, Giuseppe, Frati, Giacomo, Puri, Pier Lorenzo, De Falco, Elena, Bearzi, Claudia, Rizzi, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://www.ncbi.nlm.nih.gov/pubmed/29371598
http://dx.doi.org/10.1038/s41419-017-0174-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://www.ncbi.nlm.nih.gov/pubmed/29371598
http://dx.doi.org/10.1038/s41419-017-0174-5

Ejemplares similares